ALTBG Fundamental Analysis - CAPITAL B

Fundamental Rating

We assign a fundamental rating of 3 out of 10 to ALTBG. ALTBG was compared to 105 industry peers in the Software industry. ALTBG scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, ALTBG is valued expensive at the moment.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALTBG had positive earnings in the past year.

In the past year ALTBG had a positive cash flow from operations.

The reported net income has been mixed in the past 5 years: ALTBG reported negative net income in multiple years.

ALTBG had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

ALTBG has a Return On Assets (3.98%) which is comparable to the rest of the industry.

ALTBG has a better Return On Equity (11.13%) than 62.50% of its industry peers.

		Industry Rank	Sector Rank
ROA	3.98%
ROE	11.13%
ROIC	N/A

ROA(3y)-22.98%

ROA(5y)-12.96%

ROE(3y)-97.65%

ROE(5y)-38.94%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a Profit Margin value of 9.78%, ALTBG perfoms like the industry average, outperforming 58.65% of the companies in the same industry.

In the last couple of years the Profit Margin of ALTBG has remained more or less at the same level.

Looking at the Gross Margin, with a value of 60.18%, ALTBG is in line with its industry, outperforming 40.38% of the companies in the same industry.

In the last couple of years the Gross Margin of ALTBG has grown nicely.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	9.78%
GM	60.18%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5Y0.95%

GM growth 3Y3.05%

GM growth 5Y5.75%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALTBG does not have a ROIC to compare to the WACC, probably because it is not profitable.

ALTBG has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, ALTBG has more shares outstanding

Compared to 1 year ago, ALTBG has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 11.07 indicates that ALTBG is not in any danger for bankruptcy at the moment.

Looking at the Altman-Z score, with a value of 11.07, ALTBG belongs to the top of the industry, outperforming 93.27% of the companies in the same industry.

ALTBG has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.

Looking at the Debt to Equity ratio, with a value of 0.28, ALTBG is in line with its industry, outperforming 52.88% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.28
Debt/FCF	N/A
Altman-Z	11.07

ROIC/WACCN/A

WACC8.3%

2.3 Liquidity

A Current Ratio of 3.47 indicates that ALTBG has no problem at all paying its short term obligations.

ALTBG's Current ratio of 3.47 is amongst the best of the industry. ALTBG outperforms 87.50% of its industry peers.

ALTBG has a Quick Ratio of 3.47. This indicates that ALTBG is financially healthy and has no problem in meeting its short term obligations.

ALTBG has a Quick ratio of 3.47. This is amongst the best in the industry. ALTBG outperforms 87.50% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.47
Quick Ratio	3.47

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 105.94% over the past year.

Measured over the past years, ALTBG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.76% on average per year.

ALTBG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -32.07%.

The Revenue has been growing by 43.44% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)105.94%

EPS 3YN/A

EPS 5Y10.76%

EPS Q2Q%99.9%

Revenue 1Y (TTM)-32.07%

Revenue growth 3Y-4.3%

Revenue growth 5Y43.44%

Sales Q2Q%-33.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

The Revenue is expected to decrease by -14.41% on average over the next years. This is quite bad

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-50.97%

Revenue Next 2Y-25.26%

Revenue Next 3Y-14.41%

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 143.75, the valuation of ALTBG can be described as expensive.

ALTBG's Price/Earnings is on the same level as the industry average.

ALTBG is valuated expensively when we compare the Price/Earnings ratio to 26.84, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	143.75
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)13.36

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALTBG does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CAPITAL B

EPA:ALTBG (7/30/2025, 7:00:00 PM)

2.875

+0.21 (+8.08%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSoftware & Services

GICS IndustrySoftware

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap427.74M

Revenue(TTM)13.86M

Net Income(TTM)1.36M

AnalystsN/A

Price Target8.98 (212.35%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	143.75
Fwd PE	N/A
P/S	30.85
P/FCF	N/A
P/OCF	2287.39
P/B	35.11
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)0.02

EY0.7%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.01

FCFYN/A

OCF(TTM)0

OCFY0.04%

SpS0.09

BVpS0.08

TBVpS-0.06

PEG (NY)N/A

PEG (5Y)13.36

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	3.98%
ROE	11.13%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	9.78%
GM	60.18%
FCFM	N/A

ROA(3y)-22.98%

ROA(5y)-12.96%

ROE(3y)-97.65%

ROE(5y)-38.94%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5Y0.95%

GM growth 3Y3.05%

GM growth 5Y5.75%

F-Score5

Asset Turnover0.41

Health

		Industry Rank	Sector Rank
Debt/Equity	0.28
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	127.04%
Cap/Sales	15.39%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.47
Quick Ratio	3.47
Altman-Z	11.07

F-Score5

WACC8.3%

ROIC/WACCN/A

Cap/Depr(3y)108.27%

Cap/Depr(5y)N/A

Cap/Sales(3y)15.29%

Cap/Sales(5y)15.03%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)105.94%

EPS 3YN/A

EPS 5Y10.76%

EPS Q2Q%99.9%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-32.07%

Revenue growth 3Y-4.3%

Revenue growth 5Y43.44%

Sales Q2Q%-33.18%

Revenue Next Year-50.97%

Revenue Next 2Y-25.26%

Revenue Next 3Y-14.41%

Revenue Next 5YN/A

EBIT growth 1Y81.48%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-470.67%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-92.88%

OCF growth 3Y-56.48%

OCF growth 5Y34.81%

CAPITAL B / ALTBG.PA FAQ

What is the ChartMill fundamental rating of CAPITAL B (ALTBG.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALTBG.PA.

What is the valuation status of CAPITAL B (ALTBG.PA) stock?

ChartMill assigns a valuation rating of 0 / 10 to CAPITAL B (ALTBG.PA). This can be considered as Overvalued.

How profitable is CAPITAL B (ALTBG.PA) stock?

CAPITAL B (ALTBG.PA) has a profitability rating of 3 / 10.

What is the valuation of CAPITAL B based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CAPITAL B (ALTBG.PA) is 143.75 and the Price/Book (PB) ratio is 35.11.

Can you provide the financial health for ALTBG stock?

The financial health rating of CAPITAL B (ALTBG.PA) is 6 / 10.

CAPITAL B (ALTBG.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

CAPITAL B / ALTBG.PA FAQ

What is the ChartMill fundamental rating of CAPITAL B (ALTBG.PA) stock?

What is the valuation status of CAPITAL B (ALTBG.PA) stock?

How profitable is CAPITAL B (ALTBG.PA) stock?

What is the valuation of CAPITAL B based on its PE and PB ratios?

Can you provide the financial health for ALTBG stock?